Hotgen to Present Innovative Immunodiagnostic Solutions at ADLM 2026
Beijing Hotgen Biotech is set to showcase its latest immunodiagnostic solutions at the ADLM 2026 conference. The company aims to highlight its proprietary technology platforms and global product portfolio in the in vitro diagnostics sector.
Newswise — Beijing Hotgen Biotech Co., Ltd. (SSE Code: 688068) will participate in ADLM 2026 and showcase its innovative immunodiagnostic solutions at Booth 4020 . As an innovative company dedicated to the in vitro diagnostics (IVD) field, Hotgen is committed to providing clinical laboratories and healthcare institutions with accurate and efficient diagnostic solutions through advanced technologies.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in